X
Logo IZB Innovations- und Gründerzentrum Biotechnologie
IZB Signet

The IZB Faculty Club

Networking with a View

The Faculty Club G2B – Gateway to Biotech is a central hub for the biotech and life sciences community on the Martinsried campus. Located on the seventh floor of the CAMPUS AT HOME hotel, it is accessible to members 24/7. Featuring a gold-accented bar, a cozy fireside lounge, and a spacious terrace with sweeping Alpine views, it offers a distinctive atmosphere for personal conversations and networking.

The Faculty Club also provides the perfect setting for events. The IZB regularly hosts networking gatherings here, such as the IZBrunch. In addition, the venue can be booked exclusively for corporate functions and special occasions for up to 100 guests.

  • “At IZB, we connect with a unique network of pharmaceutical companies, research institutions, and investors – an ideal ecosystem to drive our biotechnology forward.”
    Dr. Luitpold Fried, Managing Director
  • “The IZB provides our team the perfect environment to kick-start our projects and operations and we are grateful to be part of this community.”
    Dr. Adrian Schomburg, CEO & Founder Eisbach Bio GmbH
  • “The IZB is a lighthouse for innovation. ... The provided space is essential for successfully implementing our pioneering ideas and leaving a lasting impact. ...”
    Dr. Patrick Großmann und Dr. Kilian Vogele, Invitris, managing directors
  • “Since the time we moved to the IZB, our headcount grew steadily from 6 to 60 employees. The IZB supported us continuously and we look forward to being part of the IZB in future.”
    Michael Scholl, CEO Leukocare
  • “As part of the IZB family we have access ­to a great location and an excellent start-up network.”
    Dr. Garwin Pichler, CEO, Dr. Nils Kulak, CEO, PreOmics GmbH


  • “We are pleased to be part of the IZB family, a leading innovation center in Europe and are looking forward to building a strong research team with local talent and connecting our global team to the renowned scientific community of Munich.”
    Dr. Karin Wisskirchen, Managing Director & Head of Research, Dr. Susanne Wilde, Head of Preclinical Research und Dr. Gregory Fanning, Acting-CEO SCG Cell Therapy GmbH
  • “The IZB provides our team with a valuable infrastructure and network that is conducive to our goal of opening new avenues for the treatment of solid tumors and bringing safe and effective ADCs to patients.”
    Dr. Dominik Schumacher, Dr. Jonas Helma-Smets, Tubulis
menuchevron-down